Cyxtera Results Presentation Deck

Transaction Adjusted EBITDA Bridge: Q2 2021 to Q2 2022 ($ in Millions) Cyxtera $62.3 Q2'21 +$8.7 Change in Revenue -$2.9 Change in Cost of Revenue (2) -$11.8 Change in SG&A (1) Includes pro form a EBITDA adjustments related to one-time stand-up costs, recurring expenses, restructuring & cost-savings initiatives, as well as product development & start-up costs (2) Excludes $1.3M in restructuring, impairment, site closures and related cost in Q2 22 and $58.9M in restructuring, impairment, site closures and related cost in Q2 21 +$3.6 Change in Adjustments (1) (2) $60.0 Q2'22 17

View entire presentation